Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurepo: High Dose Erythropoietin in HIE
NCT01732146Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2013
- Primary completion
- Feb 2017
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin beta in hypoxic-ischemic encephalopathy (HIE), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2013; status: completed.
02
Drugs
epoetin beta
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT01732146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01732146.